Login / Signup

Fluoropyrimidine usage in cases with hyperammonemia: real-world data study using the Japanese Adverse Drug Event Report (JADER) database.

Mitsuaki OuraFumiya OguroNobukazu AgatsumaHirotaka ImamakiYoshitaka Nishikawa
Published in: Cancer chemotherapy and pharmacology (2023)
Hyperammonemia cases were more likely to be reported with intravenous fluorouracil than orally administered fluoropyrimidines. Fluoropyrimidines might interact with CKD in hyperammonemia cases.
Keyphrases
  • adverse drug
  • electronic health record
  • emergency department
  • chronic kidney disease
  • machine learning
  • drug induced
  • low dose
  • data analysis
  • deep learning